Administration, Intranasal

"Administration, Intranasal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Delivery of medications through the nasal mucosa.

Descriptor ID	D000281
MeSH Number(s)	E02.319.267.120.655.500
Concept/Terms	Administration, Intranasal Administration, Intranasal Intranasal Drug Administration Drug Administration, Intranasal Intranasal Administration Administrations, Intranasal Intranasal Administrations Administration, Intranasal Drug Administrations, Intranasal Drug Drug Administrations, Intranasal Intranasal Drug Administrations Administration, Nasal Administrations, Nasal Nasal Administration Nasal Administrations

Below are MeSH descriptors whose meaning is more general than "Administration, Intranasal".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Drug Administration Routes [E02.319.267]
Administration, Topical [E02.319.267.120]
Administration, Mucosal [E02.319.267.120.655]
Administration, Intranasal [E02.319.267.120.655.500]

Below are MeSH descriptors whose meaning is related to "Administration, Intranasal".

Below are MeSH descriptors whose meaning is more specific than "Administration, Intranasal".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Administration, Intranasal" by people in this website by year, and whether "Administration, Intranasal" was a major or minor topic of these publications.

Bar chart showing 53 publications over 22 distinct years, with a maximum of 6 publications in 1999 and 2006

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	1	1
1999	0	6	6
2001	0	4	4
2002	0	3	3
2003	0	1	1
2004	0	2	2
2006	0	6	6
2007	1	2	3
2008	0	4	4
2009	0	1	1
2010	1	0	1
2011	0	1	1
2012	0	2	2
2013	0	1	1
2014	0	2	2
2015	0	2	2
2017	0	3	3
2018	0	3	3
2019	0	3	3
2021	0	2	2
2022	0	1	1
2023	0	1	1

Below are the most recent publications written about "Administration, Intranasal" by people in Profiles.

Joseph J, Baby HM, Quintero JR, Kenney D, Mebratu YA, Bhatia E, Shah P, Swain K, Lee D, Kaur S, Li XL, Mwangi J, Snapper O, Nair R, Agus E, Ranganathan S, Kage J, Gao J, Luo JN, Yu A, Park D, Douam F, Tesfaigzi Y, Karp JM, Joshi N. Toward a Radically Simple Multi-Modal Nasal Spray for Preventing Respiratory Infections. Adv Mater. 2024 Nov; 36(46):e2406348.

View in: PubMed
Sefat KMSR, Kumar M, Kehl S, Kulkarni R, Leekha A, Paniagua MM, Ackart DF, Jones N, Spencer C, Podell BK, Ouellet H, Varadarajan N. An intranasal nanoparticle vaccine elicits protective immunity against Mycobacterium tuberculosis. Vaccine. 2024 Sep 17; 42(22):125909.

View in: PubMed
Yu J, Li J, Matei N, Wang W, Tang L, Pang J, Li X, Fang L, Tang J, Zhang JH, Yan M. Intranasal administration of recombinant prosaposin attenuates neuronal apoptosis through GPR37/PI3K/Akt/ASK1 pathway in MCAO rats. Exp Neurol. 2024 Mar; 373:114656.

View in: PubMed
Yu S, Doycheva DM, Gamdzyk M, Gao Y, Guo Y, Travis ZD, Tang J, Chen WX, Zhang JH. BMS-470539 Attenuates Oxidative Stress and Neuronal Apoptosis via MC1R/cAMP/PKA/Nurr1 Signaling Pathway in a Neonatal Hypoxic-Ischemic Rat Model. Oxid Med Cell Longev. 2022; 2022:4054938.

View in: PubMed
Zuo Z, Zou Y, Li Q, Guo Y, Zhang T, Wu J, He C, Eko FO. Intranasal immunization with inactivated chlamydial elementary bodies formulated in VCG-chitosan nanoparticles induces robust immunity against intranasal Chlamydia psittaci challenge. Sci Rep. 2021 05 17; 11(1):10389.

View in: PubMed
Liang H, Matei N, McBride DW, Xu Y, Zhou Z, Tang J, Luo B, Zhang JH. TGR5 activation attenuates neuroinflammation via Pellino3 inhibition of caspase-8/NLRP3 after middle cerebral artery occlusion in rats. J Neuroinflammation. 2021 Feb 02; 18(1):40.

View in: PubMed
Sharma P, Levy O, Dowling DJ. The TLR5 Agonist Flagellin Shapes Phenotypical and Functional Activation of Lung Mucosal Antigen Presenting Cells in Neonatal Mice. Front Immunol. 2020; 11:171.

View in: PubMed
Sun CM, Enkhjargal B, Reis C, Zhou KR, Xie ZY, Wu LY, Zhang TY, Zhu QQ, Tang JP, Jiang XD, Zhang JH. Osteopontin attenuates early brain injury through regulating autophagy-apoptosis interaction after subarachnoid hemorrhage in rats. CNS Neurosci Ther. 2019 10; 25(10):1162-1172.

View in: PubMed
Okada T, Enkhjargal B, Travis ZD, Ocak U, Tang J, Suzuki H, Zhang JH. FGF-2 Attenuates Neuronal Apoptosis via FGFR3/PI3k/Akt Signaling Pathway After Subarachnoid Hemorrhage. Mol Neurobiol. 2019 Dec; 56(12):8203-8219.

View in: PubMed
Liu SP, Huang L, Flores J, Ding Y, Li P, Peng J, Zuo G, Zhang JH, Lu J, Tang JP. Secukinumab attenuates reactive astrogliosis via IL-17RA/(C/EBP?)/SIRT1 pathway in a rat model of germinal matrix hemorrhage. CNS Neurosci Ther. 2019 10; 25(10):1151-1161.

View in: PubMed

People

Explore

Similar Concepts

Top Journals